Compile Data Set for Download or QSAR
Report error Found 92 Enz. Inhib. hit(s) with all data for entry = 5921
TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100728(US8507676, 78)
Affinity DataIC50: 0.400nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100726(US8507676, 77-S)
Affinity DataIC50: 0.480nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100724(US8507676, 75-S)
Affinity DataIC50: 1.20nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100659(US8507676, 8)
Affinity DataIC50: 1.80nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100674(US8507676, 23)
Affinity DataIC50: 2.20nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100673(US8507676, 22)
Affinity DataIC50: 2.40nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100663(US8507676, 12-S)
Affinity DataIC50: 2.5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100707(US8507676, 56)
Affinity DataIC50: 2.5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100666(US8507676, 15)
Affinity DataIC50: 2.80nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100703(US8507676, 51-S | US8507676, 51-R)
Affinity DataIC50: 2.80nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100675(US8507676, 24)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100705(US8507676, 69 | US8507676, 54)
Affinity DataIC50: 3nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM2214(US8507676, 53-S)
Affinity DataIC50: 3.5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100691(US8507676, 38)
Affinity DataIC50: 3.60nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM2221(US8507676, 80)
Affinity DataIC50: 3.80nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100706(US8507676, 55)
Affinity DataIC50: 3.80nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100690(US8507676, 37B)
Affinity DataIC50: 3.90nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100705(US8507676, 69 | US8507676, 54)
Affinity DataIC50: 4.70nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100672(US8507676, 21)
Affinity DataIC50: 5.10nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100670(US8507676, 19)
Affinity DataIC50: 5.40nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100657(US8507676, 6)
Affinity DataIC50: 5.5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100662(US8507676, 11-S)
Affinity DataIC50: 6nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100714(US8507676, 63 | US9062045, Comparator No. 2)
Affinity DataIC50: 6nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100660(US8507676, 9)
Affinity DataIC50: 6.70nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100721(US8507676, 71)
Affinity DataIC50: 7nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100695(US8507676, 42)
Affinity DataIC50: 7nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100729(US8507676, 79)
Affinity DataIC50: 7.10nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100667(US8507676, 16)
Affinity DataIC50: 7.30nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100654(US8507676, 3)
Affinity DataIC50: 8nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100718(US8507676, 67)
Affinity DataIC50: 8nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100678(US8507676, 26B)
Affinity DataIC50: 9nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100694(US8507676, 41)
Affinity DataIC50: 10nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100653(US8507676, 2)
Affinity DataIC50: 10nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100722(US8507676, 72)
Affinity DataIC50: 11nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100704(US8507676, 52)
Affinity DataIC50: 11nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100736(US8507676, 73)
Affinity DataIC50: 12nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100686(US8507676, 34)
Affinity DataIC50: 12nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100697(US8507676, 44)
Affinity DataIC50: 13nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100719(US8507676, 68-S | US8507676, 68-R)
Affinity DataIC50: 13nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100709(US8507676, 58)
Affinity DataIC50: 14nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100716(US8507676, 65)
Affinity DataIC50: 15nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100689(US8507676, 37A)
Affinity DataIC50: 16.5nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100723(US8507676, 74)
Affinity DataIC50: 17nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100715(US8507676, 64)
Affinity DataIC50: 18nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100737(US8507676, 75-R)
Affinity DataIC50: 19nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM2212(US8507676, 39-S)
Affinity DataIC50: 19nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100677(US8507676, 26A)
Affinity DataIC50: 20nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100727(US8507676, 77-R)
Affinity DataIC50: 20nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100713(US8507676, 62-S)
Affinity DataIC50: 21nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Novartis

US Patent
LigandPNGBDBM100661(US8507676, 10)
Affinity DataIC50: 24nMAssay Description:The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
US Patent

Displayed 1 to 50 (of 92 total ) | Next | Last >>
Jump to: